Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TD Tele-Doc Weight Loss vs Vaylen

TD Tele-Doc Weight Loss
Graded #286

Lower grade

vs+16.10000000000001
Vaylen
Graded #44

Higher grade

The verdict

Vaylen takes it — 77.9/100 to 61.8/100.

Vaylen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVaylen +22
45
67
Dose & formulationVaylen +35
53
88
Clinical oversightTD Tele-Doc Weight Loss +4
88
84
Labs & monitoringVaylen +12
65
77
FulfillmentVaylen +22
68
90
Contract termsEven
55
55
TD Tele-Doc Weight Loss · left barVaylen · right bar

The numbers

MetricTD Tele-Doc Weight LossVaylen
WeighScore61.8/10077.9/100
GradeCC+
Scorecard rank#286#44
SemaglutideNot disclosed$179/mo (compounded)
TirzepatideNot disclosed$239/mo (compounded)
Coverage2 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
TD Tele-Doc Weight Loss

Graded #286 · C

Strengths

  • Brand Wegovy/Zepbound AND compounded sema available; prescribing based on medical history and coverage
  • 100% virtual — weekly appointments with board-certified MDs from home; no travel required
  • Remote Patient Monitoring Starter Box: biometric scale + blood pressure cuff sync to care team in real time
  • In-network with most commercial insurance plans; may cover visits and monitoring equipment
  • Physician-led by Dr. Peter Wilbanks MD (30-yr OB/GYN, VCU) and Dr. Michael Perini MD (ABIM board-certified)

Where it loses points

  • No public cash pricing; cost entirely depends on insurance coverage — not viable for uninsured patients
  • Telehealth available only in Virginia and Maryland; no national reach confirmed
  • No Medicare or Medicaid accepted; limited to commercial insurance plans only
  • No LegitScript certification found; compounded availability and specific pricing undisclosed on site
  • Tirzepatide (Zepbound/Mounjaro) availability less prominent in MD pages; semaglutide is primary focus
Vaylen

Graded #44 · C+

Strengths

  • Pure GLP-1 specialist — not a multi-category telehealth platform
  • All 50 states coverage with licensed clinicians
  • Both compounded and brand-name options (Ozempic, Wegovy, Zepbound)
  • Oral GLP-1 option (compounded dissolvable tablets) for needle-averse patients
  • LegitScript certified

Where it loses points

  • Compounded semaglutide at $179/mo is mid-range (not the cheapest)
  • Brand-name options at near-retail pricing ($997-$1,086/mo)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard